A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma

Completed · Phase 2 · Has a placebo group

Conditions studied: Asthma

In brief

The purpose of this study is to evaluate the safety and effectiveness of once daily oral administration of JNJ-39758979 in the treatment of adults (18 to 65 years of age) with persistent asthma.

Key facts

Study ID

NCT00946569

Run by

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

People needed

116

Starts

2009-08-01

Expected to finish

2010-09-01

Last updated by the study team

2014-04-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed diagnosis of asthma for at least 6 months
• Short-acting beta-agonist use greater than or equal to 5 times in the 2 weeks prior to screening
• Healthy on the basis of physical examination, medical history, vital signs, and 12 lead ECG performed at screening
• Having adequate laboratory values
• No history of/active or latent tuberculosis
• Agree to use protocol defined contraceptive methods

You may not qualify if…

• History of life-threatening asthma attack requiring hospitalization for asthma within 5 years of screening, or emergency department treatment of asthma within the last month
• Moderate or severe renal insufficiency
• Cigarette smoking within the last year - Viral or bacterial vaccination within the last month (eg, FluMist)
• Human Immunodeficiency Virus (HIV) or Hepatitis B or C positive

Where it is running

• Study site — Scottsdale, Arizona, United States
• Study site — Cypress, California, United States
• Study site — Los Angeles, California, United States
• Study site — San Diego, California, United States
• Study site — Normal, Illinois, United States
• Study site — North Dartmouth, Massachusetts, United States
• Study site — Papillion, Nebraska, United States
• Study site — Cincinnati, Ohio, United States
• Study site — Oklahoma City, Oklahoma, United States
• Study site — Medford, Oregon, United States
• Study site — Portland, Oregon, United States
• Study site — Dallas, Texas, United States
• Study site — Waco, Texas, United States
• Study site — Madison, Wisconsin, United States
• Study site — Kelowna, British Columbia, Canada
• Study site — Niagara Falls, Ontario, Canada
• Study site — Ottawa, Ontario, Canada
• Study site — Toronto, Ontario, Canada
• Study site — Québec, Quebec, Canada
• Study site — Chennai, India
• Study site — Mumbai, India
• Study site — Mysore, India
• Study site — Pune, India
• Study site — Bucharest, Romania

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.